Fosfazinomycin and kinamycin are natural products that contain nitrogennitrogen (N-N) bonds but that are otherwise structurally unrelated. Despite their considerable structural differences, their biosynthetic gene clusters share a set of genes predicted to facilitate N-N bond formation. In this study, we show that for both compounds, one of the nitrogen atoms in the N-N bond originates from nitrous acid. Furthermore, we show that for both compounds, an acetylhydrazine biosynthetic synthon is generated first and then funneled via a glutamyl carrier into the respective biosynthetic pathways. Therefore, unlike other pathways to N-N bond-containing natural products wherein the N-N bond is formed directly on a biosynthetic intermediate, during the biosyntheses of fosfazinomycin, kinamycin, and related compounds, the N-N bond is made in an independent pathway that forms a branch of a convergent route to structurally complex natural products.
Despite the diversity of N-N bonds found in natural products, relatively little is currently known about their biosyntheses. Based on the available biosynthetic gene clusters, the biosynthetic logic of N-N bond formation appears to be at least partially shared among certain groups of compounds. Recently, N-N bond formation was reconstituted in vitro for kutzneride, showing that N5 on ornithine is oxidized to give N5hydroxyornithine by a flavin-dependent enzyme before the N-N bond is formed by a heme protein (Supplementary Fig. 1a ) 5 . Thus, for this compound, one nitrogen is activated to a more electrophilic species and then reacted intramolecularly with a nucleophilic nitrogen.
A different strategy towards N-N bond formation features the formal reaction of a nitrogen-containing intermediate with nitrous acid. For instance, during the biosynthesis of cremeomycin, a flavin-dependent monooxygenase, CreE, oxidizes aspartic acid to nitrosuccinic acid (1, Fig. 1b) , and a lyase, CreD, subsequently liberates nitrous acid 6 .
Nitrous acid is then proposed to partake in diazotization with a primary aromatic amine on an advanced intermediate to form the N-N bond, but the details of this process and whether it requires an enzyme remain unclear ( Supplementary Fig. 1b) 7 . Recently, we reported that the fosfazinomycin biosynthetic enzymes FzmM and FzmL, homologs of CreE and CreD respectively, can also produce nitrous acid from aspartic acid with Nhydroxyaspartic acid (2, Fig. 1b) as an intermediate 8 . Moreover, we showed that aspartic acid is incorporated into at least one of the nitrogen atoms in the phosphonohydrazide moiety of fosfazinomycin. Interestingly, a set of five genes is conserved between the biosynthetic gene clusters of fosfazinomycin (fzm) and kinamycin (kin) ( Fig. 1c) , suggesting that the two compounds may share biosynthetic steps. These genes are predicted to encode homologs of a glutamine synthetase (FzmN/KinL), an amidase (FzmO/KinK), a hypothetical protein (FzmP/KinJ), an Nacetyltransferase (FzmQ/KinN), and an adenylosuccinate lyase (FzmR/KinM) 9, 10 . The roles of these five enzymes in installing the N-N bond into two structurally divergent compounds are not known. In our prior work concerning the biosynthesis of fosfazinomycin, we reconstituted in vitro the activities of FzmQ and FzmR. FzmQ performs the acetylation of hydrazinosuccinic acid (3) to yield N-acetylhydrazinosuccinic acid (4, Fig. 1b) , and FzmR catalyzes an elimination reaction of 4 to afford fumaric acid and acetylhydrazine 8 .
In this study we show via isotope labeling experiments that one of the nitrogen atoms in the N-N bonds of both fosfazinomycin and kinamycin originates from nitrous acid. Additional feeding experiments and reconstitution of enzymatic activities confirm the intermediacies of 2, 4, and acetylhydrazine in both biosynthetic pathways.
Moreover, we demonstrate that after the N-N bond is formed, the hydrazine moiety is installed onto the side chain carboxyl group of glutamic acid. These results reveal that during the biosyntheses of both fosfazinomycin and kinamycin, the N-N bond is formed from aspartic acid as a discrete and separate synthon before being shuttled into the two respective biosynthetic pathways using glutamic acid as carrier. Thus, these pathways are fundamentally different from the biosynthetic routes to kutzneride and cremeomycin in which the N-N bond is formed directly on a biosynthetic intermediate.
Results

Confirmation of fosfazinomycin biosynthetic intermediates by feeding experiments
In previous work, we showed using stable isotope labeling experiments that at least one of the nitrogen atoms in the phosphonohydrazide linkage in fosfazinomycin is derived from aspartic acid 8 . Furthermore, reconstitution of the activities of FzmM and FzmL demonstrated that they produce nitrous acid from aspartic acid; however, we also found that under certain conditions, FzmM converted aspartic acid to N-hydroxyaspartic acid (2) 8 . In light of the recent work on kutzneride and cremeomycin, it was unclear whether the generation of 2 by FzmM is a direct intermediate in N-N bond formation (similar to kutzneride, Supplementary Fig. S1a ) or if 2 is only an intermediate in the oxidation of aspartic acid to 1 (similar to cremeomycin, Supplementary Fig. S1b ) 5, 7 . In order to investigate these possibilities, we performed isotope labeling studies in the native producing organism of fosfazinomycin, Streptomyces sp. NRRL S-149. First, the organism was cultivated in a minimal medium with 15 NH4Cl and 15 N-aspartic acid as the only two sources of nitrogen, and analysis by liquid chromatography-high resolution mass spectrometry (LC-HRMS) of the spent medium revealed a singly charged peak ([M+H] + = 461.1957 Da) corresponding to fosfazinomycin A containing seven 15 N atoms ( Fig. 2a) . Cultures grown in uniformly 15 N-labeled medium were then fed sodium nitrite at natural isotopic abundance. LC-HRMS analysis of the spent medium revealed a clear increase in the peak corresponding to [M+H] + =460.1996 Da (Fig. 2b) , one mass unit lower than uniformly 15 N-labeled fosfazinomycin. Integration of the peak areas showed that approximately 30% of the product contains a single 14 N atom originating from nitrite. We next fed 2 at natural abundance to Streptomyces sp. NRRL S-149 grown in medium containing 15 NH4Cl and 15 N-aspartic acid as the only two other sources of nitrogen. As with nitrite, a significant peak with [M+H] + = 460.1993 Da was observed ( Fig. 2c ), corresponding to a single incorporation (20%) of 14 N into fosfazinomycin.
We next performed tandem mass spectrometry (MS/MS) analysis to determine if the 14 N atoms from nitrite and 2 were incorporated into the hydrazide linkage of fosfazinomycin. First, as a control, uniformly 15 N-labled fosfazinomycin ([M+H] + = 461.20) was subjected to higher energy collisional dissociation (HCD), and the product and fragment ions were assigned ( Supplementary Fig. 2a ). Then, the spent medum from the culture cultivated with added unlabeled sodium nitrite was analyzed focusing on a precursor ion ([M+H] + = 460.20) corresponding to singly 14 N-labeled fosfazinomycin ( Supplementary Fig. 2b) . Analysis of the fragment ions indicated 14 Fig.   2c ). Again, only fragment ions containing the N-N bond (ions g, j, and k) incorporated 14 N. Thus, these feeding experiments demonstrate that one of the nitrogens in the phosphonohydrazide linkage in fosfazinomycin is derived from nitrite. These data are also consistent with our previous study that showed that nitrite is formed from Asp with 2 as an intermediate.
We next performed additional feeding experiments to confirm that 3 and acetylhydrazine are also competent intermediates in the fosfazinomycin biosynthetic pathway. When 3 at natural isotopic abundance was fed to the producing organism grown in 15 N-labeled medium, the product ions showed a large increase in a peak two mass units lower [M+H] + = 459.2013) than the uniformly 15 N-labeled product (Fig. 2d) .
The data demonstrate about 50% double incorporation of 14 N into fosfazinomycin.
Similarly, when acetylhydrazine (nitrogen at natural isotopic abundance) was added to the 15 N-labeled medium, a large increase in a peak two mass units lower ([M+H] + = 459.2015) relative to the control was observed, indicating two incorporations of 14 N (40%) into fosfazinomycin A ( Fig. 2e) . MS/MS was then used to determine the location of 14 Fig. 2e ). Thus, these data strongly suggest that 3 and acetylhydrazine are intermediates in the pathway and that both of their nitrogen atoms are incorporated selectively into the phosphonohydrazide linkage of fosfazinomycin, consistent with the demonstration that in vitro FzmQR convert 3 to acetylhydrazine 8 .
Feeding studies in a kinamycin producer
As described in the introduction, the kinamycin biosynthetic gene cluster contains genes that are homologous to fzmQR, suggesting that 3 and acetylhydrazine might also be intermediates in its biosynthesis. Furthermore, kinamycin D has been recently reconstituted in vivo in S. albus J1074, and its heterologous expression has been demonstrated to be dependent on alp2F and alp2G, orthologs of fzmM and fzmL 11 .
Thus, to investigate whether the products of FzmLM are incorporated into kinamycin, we performed a series of stable isotope feeding studies.
We began by supplementing the fermentation medium of S. murayamaensis, a prolific producer of kinamycin D 12 , with 1 mM of 15 N-nitrite ( Fig. 3a) . LC-HRMS analysis of the organic extracts from the 15 N-nitrite-fed cultures revealed ~90% enrichment of singly labeled kinamycin D ([M+H] + = 456.1055) ( Fig. 3b) . We isolated the natural product and observed by 1D 15 N-NMR spectroscopy that the proximal nitrogen of the diazo group is exclusively enriched (Fig. 3c) . This outcome contrasts sharply with the results of previous 15 N-nitrite feeding experiments performed with the producers of the diazo-containing secondary metabolite SF2415A3, in which only the distal diazo nitrogen atom was labeled ( Supplementary Fig 1c) 3 . In this study, both 15 N-nitrite and 15 N-nitrate selectively enriched the distal diazo nitrogen atom. We tested whether 15 Nnitrate also labeled the diazo group of kinamycin D. After culturing S. murayamaensis in the presence of 1 mM 15 N-nitrate, we also observed ~80% enrichment of the proximal nitrogen ( Fig. 3ac) . Diazo formation in the biosynthesis of kinamycin had been proposed to occur via a late-stage N-N bond formation involving an aminobenzo[b]fluorene biosynthetic precursor such as stealthin C, a biosynthetic logic that would parallel that of SF2415A3 ( Supplementary Fig. 1cd ) 13 . The localization of 15 N label to the proximal diazo nitrogen atom in our feeding experiments shows that this is not the case, and supports the involvement of an alternative strategy for diazo installation in kinamycin biosynthesis.
Reconstitution of KinNM activity
To further demonstrate that 3 and acetylhydrazine are also relevant intermediates in the biosynthesis of kinamycin, we first sequenced the genome of S. murayamaensis and identified the homologs of FzmNOPQR, which we have labeled as KinLKJNM, respectively. Then we expressed and purified KinN and KinM, which are homologs of FzmQ and FzmR, respectively. We observed the conversion of 3 to 4 by KinN in the presence of acetyl-CoA ( Supplementary Fig. 3ab ). Compound 4 was converted by KinM into acetylhydrazine and fumaric acid as monitored by 1 H-NMR spectroscopy and LC-HRMS ( Supplementary Fig. 3ac ). We next synthesized doublylabeled 15 N2-acetylhydrazine and fed this substrate to S. murayamaensis. We observed 20% enrichment of both nitrogen atoms of kinamycin D by LC-HRMS ([M+H] + = 457.1026) ( Supplementary Fig. 3d ). These results indicate a role for KinNM and acetylhydrazine in assembling the diazo group of kinamycin D.
Reconstitution of FzmN and KinL activity
Having confirmed that the nitrogen atoms involved in the hydrazide linkage of fosfazinomycin and the diazo group in kinamycin likely have common origins, we next focused on other enzymes encoded by the conserved five-gene cassette. FzmN is a glutamine synthetase homolog, a class of enzymes that canonically catalyzes the formation of glutamine from glutamic acid and ammonia. We first tested whether FzmN could catalyze this prototypical reaction. FzmN was expressed recombinantly in E. coli with an N-terminal His6-tag. The purified recombinant protein was then incubated with glutamic acid and ammonium chloride in the presence of ATP and MgCl2 (Fig. 4a) .
When the reaction was analyzed by 1 H NMR spectroscopy, a new peak was observed at 2.24 ppm that was absent when FzmN was omitted ( Fig. 4bc) . This new resonance is consistent with the γ-protons on glutamine, and this assignment was confirmed by spiking with a glutamine standard.
FzmQ and FzmR convert 3 to acetylhydrazine 8 , and the labeling studies described above establish that both of the nitrogen atoms from 3 and acetylhydrazine are incorporated selectively into the phosphonohydrazide linkage of fosfazinomycin.
Thus, we reasoned that the next step in the biosynthetic pathway could involve acetylhydrazine as a substrate. Indeed, FzmN catalyzes the condensation of glutamic acid and acetylhydrazine to form glutamylacetylhydrazine (5) in the presence of ATP and MgCl2 (Fig. 4d) . When the reaction was analyzed by 1 H NMR spectroscopy, two new resonances belonging to (5) at 2.28 ppm and at 1.92 ppm were observed that were absent when FzmN was withheld from the reaction mixture ( Fig. 4ef) .
Kinetic parameters were determined for FzmN using a coupled enzyme assay with pyruvate kinase and lactate dehydrogenase, measuring NADH consumption by UV-vis spectroscopy. First, the canonical glutamine synthetase reaction with ammonium chloride as a substrate was analyzed, yielding a kcat of 0.91±0.02 s -1 and a KM of 17±1 mM (Supplementary Fig. 4a ). The FzmN reaction with acetylhydrazine displayed a similar kcat (~1.4 s -1 ), but acetylhydrazine was such a good substrate that the Km could not be determined and is at least three orders of magnitude lower than the Km of ammonia (Km,acetylhydrazine < 10 μM) ( Supplementary Fig. 4b ). Together, these results strongly suggest that the condensation of acetylhydrazine and glutamic acid is the role of FzmN in the biosynthesis of fosfazinomycin.
We also tested KinL, the homolog of FzmN encoded in the kin biosynthetic gene cluster, for this ligase activity. While we were not able to obtain this enzyme in soluble active form, we confirmed its activity in vivo by feeding acetylhydrazine to E. coli expressing KinL (Supplementary Fig. 5a ). Compound 5 was observed in culture supernatants only when KinL was expressed and acetylhydrazine was present in the media (Supplementary Fig. 5b ). These results demonstrate that KinL possesses analogous reactivity to FzmN.
Reconstitution of FzmO activity
We next turned our attention towards FzmO, an amidase homolog shared between the biosynthetic pathways of fosfazinomycin and kinamycin. Despite numerous different attempts, we were unable to express recombinant FzmO solubly in E. coli. We then endeavored to refold the protein in vitro. FzmO, expressed with an N-terminal His6-tag, was extracted from inclusion bodies with buffers containing guanidine hydrochloride. After purification with nickel affinity chromatography, the protein was diluted into 216 different buffers in 96-well plates 14 . We were able to identify conditions that resulted in solubilized FzmO by measuring the turbidity of the wells with a plate reader. The refolded soluble FzmO was then assessed for enzymatic activity.
Glutamyl-acetylhydrazine (5), the product of the FzmN-catalyzed reaction, contains an acetyl group that would likely have to be lost prior to funneling the hydrazine synthon into fosfazinomycin biosynthesis. Likewise, in kinamycin biosynthesis, removal of the acetyl group will be necessary before the formation of the final product. Thus, we investigated whether FzmO, being an amidase homolog, might catalyze such a reaction. Refolded FzmO was incubated with 5, and the products in the reaction mixture were derivatized with fluorenylmethyloxycarbonyl chloride (Fmoc-Cl) to facilitate reversed-phase LC-MS analysis (Fig. 5a) . When the reaction mixture was analyzed by LC-MS, a mass consistent with glutamylhydrazine (6) was detected that was absent when FzmO was omitted from the reaction (Fig. 5bc) . To confirm the presence of 6, a synthetic standard was prepared, and LC-MS analysis revealed that the synthetic material eluted with the same retention time as the product of the FzmO-catalyzed reaction (Fig. 5d) . The assignment was confirmed by spiking the synthetic standard into the reaction mixture (Fig. 5e) . The FzmO-catalyzed hydrolysis appears to be selective for the acetylhydrazide linkage over the glutamylhydrazide bond since glutamic acid could not be detected after the reaction (Fig. 5fg) .
The kin gene cluster encodes a homolog of FzmO, KinK. We demonstrated that 6, the presumed product of KinK-mediated hydrolysis, is an on-pathway intermediate in the biosynthesis of kinamycin D using feeding experiments. We synthesized doubly labeled 15 N2-L-glutamylhydrazide (6) and supplemented the fermentation broth of S. murayamensis with this compound at a final concentration of 200 μM, as higher concentrations were found to have an adverse effect on growth and production of kinamycin D. We observed 60% enrichment of the diazo group in kinamycin D (Fig. 5h) .
This observation confirms that this functional group derives from a hydrazine-bound glutamyl scaffold.
Reconstitution of FzmA activity
Having reconstituted the production of 6 by FzmO, we next explored ways in which the hydrazine moiety of 6 could be transferred onto the carboxyl group of arginine since our previous work suggested that argininylhydrazine is an intermediate in the biosynthesis of fosfazinomycin 15 . Such a reaction would minimally require both the breakage and formation of a hydrazide linkage. FzmA, an asparagine synthetase homolog, stood out as a prime candidate to catalyze this reaction. Bifunctional asparagine synthetases contain a glutaminase domain that hydrolyzes the side chain carboxamide of glutamine to liberate ammonia, which travels through a tunnel to a distal synthetase active site where aspartic acid is adenylated and reacted with the ammonia 16 . To assess enzymatic activity, FzmA was expressed recombinantly in E. coli bearing a C-terminal His6-tag since the N-terminal cysteine residue is critical for catalysis in canonical asparagine synthetases. After the recombinant protein was incubated with 6, the products of the reaction mixture were derivatized with Fmoc-Cl. Fig. 6a ), whereas this product was not observed when FzmA was omitted from the reaction (Supplementary Fig. 6b ). At present we have not been able to observe condensation of the hydrazine with arginine to form argininylhydrazine, but FzmA clearly has the ability to liberate hydrazine from glutamylhydrazine.
Fmoc-Glu was detected by LC-MS (Supplementary
Free hydrazine is not involved in diazo installation in kinamycin biosynthesis
The fosfazinomycin and kinamycin biosynthetic pathways employ the key intermediate 6 in distinct ways. To construct the diazofluorene scaffold of the kinamycins, the hydrazine moiety of 6 must be hydrolyzed and transferred to a polyketide intermediate. We have previously reported that an electrophilic species generated from the biosynthetic intermediate dehydrorabelomycin by the flavin monooxygenase AlpJ/KinO1 can be attacked non-enzymatically by a variety of amine nucleophiles ( Fig. 6) 17 . We envisioned that hydrazine liberated from 6 could attack this scaffold to generate a hydrazine adduct, which could be further oxidized to afford the diazofluorene. However, this reaction is unlikely to involve non-enzymatic addition of free hydrazine as we would have observed labeling of both the distal and proximal diazo nitrogen atoms in our 15 N-nitrite and 15 N-nitrate feeding experiments ( Fig. 3) .
To test whether free 15 N2-hydrazine can directly label kinamycin D, we added 15 N2-hydrazine to the fermentation broth of S. murayamaensis at a concentration of 0.2 mM, the same concentration at which we fed 15 N2-6. At this concentration, we observed 0% labeling (Supplementary Fig. 7b ). At 1 mM concentration, we observed ~40% labeling of both diazo nitrogen atoms by mass spectrometry (Supplementary Fig. 7) .
We hypothesized that KinL might exhibit promiscuous ligase activity, generating 15 N2-6 from 15 N2-hydrazine directly in the producing strain. To test this proposal, we fed 1 mM hydrazine to E. coli expressing KinL and observed production of 6 only when KinL was expressed and hydrazine was present (Supplementary Fig. 5c ). Therefore, the labeling we observed from feeding 15 N2-hydrazine likely arises from its incorporation into 6 by KinL.
Discussion
The in vivo feeding experiments presented here demonstrate that one of the nitrogen atoms in the N-N bonds of both fosfazinomycin and kinamycin is derived from nitrous acid, similar to findings in the biosynthesis of cremeomycin. But unlike in the biosynthesis of cremeomycin, for which it has been proposed that the diazo group is formed late in the pathway from a pre-installed aromatic amine, we show that in the biosyntheses of fosfazinomycin and kinamycin, the N-N bond is made early and that the hydrazine functionality is carried through multiple enzymatic steps. Our feeding experiments corroborate the previously reconstituted in vitro activities of FzmQ and FzmR, thus firmly establishing that their physiological roles are indeed the acetylation of hydrazinosuccinate and the elimination of acetylhydrazine, respectively (Fig. 6) . Further, the reconstitution of the activities of KinN and KinM, the homologs of FzmQ and FzmR in the kinamycin biosynthetic cluster and the results of the feeding studies for kinamycin production illustrate that these steps are conserved in the biosynthetic pathways towards fosfazinomycin and kinamycin. These findings are surprising since previous studies had suggested that the N-N bond in the diazo group of kinamycin was fashioned from an aromatic nitrogen-containing precursor, analogous to the proposal for cremeomycin, but such a pathway is inconsistent with the labeling studies presented here.
To follow the fate of acetylhydrazine, we also reconstituted the activities of FzmN and FzmO, revealing that acetylhydrazine is first condensed onto the side chain carboxyl group of glutamic acid to form glutamylacetylhydrazine (5) before deacetylation to yield glutamylhydrazine (6) . Glutamic acid is present in relatively high concentrations in the cytoplasm of most bacteria, and perhaps for that reason, glutamic acid has previously been demonstrated to be a common carrier molecule to effect many different types of transformations 18 In the fosfazinomycin biosynthetic pathway, we previously reported that argininylhydrazine is the substrate for the N-methyltransferase FzmH 15 . Thus, the next step in the biosynthesis after formation of 6 likely involves the transfer of hydrazine from the side chain of glutamic acid onto the carboxyl group of arginine. FzmA, an asparagine synthetase homolog, might catalyze such a reaction (Fig. 6) . Indeed, we have reconstituted the hydrolysis of 6 by FzmA, liberating hydrazine. While at the present, we have yet to reconstitute the enzymatic formation of argininylhydrazine by (Supplementary Fig. 1e) 21 .
This work provides further support for a major revision in the proposed biosynthetic pathway for kinamycin and the other diazofluorene polyketides. A previous study had suggested that stealthin C is a biosynthetic intermediate to kinamycin on the basis of isotope labeling studies; however, that study measured the incorporation of deuterated stealthin C, and only low percentages of incorporation were observed ( Supplementary Fig. 1d) 13 . Furthermore, we have recently reported that stealthin C can be formed nonenzymatically in vivo and in vitro 17 . Therefore, we posit that stealthin C is not an authentic intermediate in kinamycin biosynthesis, and instead, the N-N bond is formed independently and later added to the polyketide scaffold in a convergent biosynthetic process. Not only do we observe the intact incorporation of the preformed N-N bond into kinamycin, we observe the incorporation of nitrite into the proximal nitrogen in the diazo functionality, which precludes a pathway involving late-stage diazotization. The exact N-N bond-containing intermediate transferred to the polyketide scaffold and the enzymes involved in this process remain to be elucidated.
Collectively, our results show that in the biosyntheses of the structurally highly diverse compounds fosfazinomycin and kinamycin, a hydrazine building block is channeled into the biosynthetic pathways by a common strategy. The N-N bond is first fashioned by conversion of aspartic acid to hydrazinosuccinic acid (3) in a process that involves nitrite but that has yet to be fully understood. Then a set of four conserved enzymes transfer the hydrazine moiety onto the side chain of glutamic acid before its final installation onto the mature natural product (Fig. 6 ). This strategy is vastly different than in the biosyntheses of other N-N bond-containing natural products for which the N-N bond is formed directly on the scaffold of the final product. Thus, this study brings to light an unexpected new pathway for the incorporation of N-N bonds in natural products.
Online Methods
General methods
All reagents and materials for the fosfazinomycin and kinamycin biosynthetic studies were purchased from Sigma-Aldrich or Fisher Scientific unless otherwise noted. MiSeq reads of two 280 bp paired-end libraries 23, 24 . Annotations were carried out using Era7's tool BG7. Sequence alignments were performed with Geneious. The S. murayamaensis genome has been deposited into NCBI (Accession # TBD)
Isotope labeling experiments
Streptomyces sp. NRRL S-149 was first cultivated on R2A agar and then in ATCC 172 medium as previously described 8 Supplementary Table 1 and Phusion polymerase. The PCR products were then purified using the QIAquick PCR Purification Kit (Qiagen). pET15b was linearized using NdeI, amplified by PCR with Phusion polymerase (primers listed in Supplementary   Table 1 ), and treated with DpnI. fzmN and fzmO were ligated into the pET15b backbone, and fzmA was ligated into pET23b (digested with NdeI and XhoI) using the Gibson Assembly kit from New England Biosciences. E. coli DH5α was used for DNA manipulation. The fidelity of the insertion was verified by sequencing. pET28a and the genes encoding KinK, KinL, and KinM were amplified using the primers listed in Supplementary Table 1 . The linear vector and the insert were ligated using Gibson Assembly Kit from New England Biosciences. The insertions were verified by sequencing.
The codon-optimized gene encoding AspB from Bacillus sp. YM55-1 was ordered from IDT as a gBlock. Following PCR amplification with Q5 polymerase (primers and synthetic gene in Supplementary Table 1) , aspB was ligated into pET15b (digested with NdeI and HindIII) using the HiFi Assembly Mix from New England Biosciences. The fidelity of the insertion was verified by sequencing.
Protein purification and refolding
For FzmN and FzmA, the protein was expressed and purified in a manner as previously reported 8 . FzmO was expressed using the same methodology as for FzmN.
After cell lysis, the insoluble fraction was resuspended in pellet wash buffer (50 mM NaH2PO4, 300 mM NaCl, 0.10% Triton X-100, pH=7.5) and passed through a 20G syringe needle several times. Again the insoluble fraction was isolated from the supernatant via centrifugation, and the pellet was resuspended in denaturing wash buffer (50 mM NaH2PO4, 300 mM NaCl, 6 M guanidine HCl, 10 mM imidazole, 10% glycerol, pH=7.5) and incubated at 56 ˚C for 15 min. After centrifugation, the supernatant was applied to Ni-NTA agarose resin (Qiagen). Nickel affinity purification proceeded similarly as with FzmN, except all buffers also contained 6 M guanidine hydrochloride.
Protein refolding conditions for FzmO were then screened using a platform adapted from another study 26 . Briefly, 100 µL of 216 different buffers was placed into three clear round bottom 96-well plates (Corning) ( Supplementary Table 2 For AspB, pET15b_aspB was used to transform electrocompetent E. coli BL21 (DE3) cells. Transformants were cultivated for 12 h at 37 ˚C in LB with 100 µg/mL ampicillin, and 10 mL of this culture was then used to inoculate a 1 L of culture in LB with 100 µg/mL ampicillin. Cultivation continued at 37 ˚C, shaking at 220 rpm, until OD600 reached between 0.5 and 0.7, and IPTG was added to 100 µM. The culture was grown for an additional 16 h at 18 ˚C with shaking at 220 rpm. AspB was then purified in the same manner as described for FzmN. pET28a_kinN and pET28a_kinM were used to transform chemically competent E. coli BL21 (DE3) cells, and the resulting transformants were cultivated overnight in 12 mL of starter cultures at 37 ˚C in LB with 50 µg/mL of kanamycin. The next day, 10 mL of this starter culture was used to inoculate 1 L of LB medium containing 50 µg/mL of kanamycin, which was allowed to incubate at 37 ˚C, shaking at 180 rpm, until reaching an OD600 of ~0.4-0.6. Then, 200 µM of IPTG was added, and the culture was grown for 
Enzyme assays
To test whether FzmN could catalyze the canonical glutamine synthetase reaction, 5 mM glutamic acid, 6 mM NH4Cl, 50 µM FzmN, 6 mM ATP, and 6 mM MgCl2 were incubated in 50 mM NaH2PO4, pH=7.7 for 5 h at room temperature. The reaction mixture was then treated with Chelex 100 resin for 15 min, and the enzyme was In order to test if FzmO is able to deacetylate glutamylacetylhydrazine (5), 50 µL was withdrawn from a well in the 96-well plate that was defined as a hit (~10 µM FzmO in 50 mM HEPES, 100 mM KCl, 20% glycerol, 800 mM arginine, pH = 9.0) in the refolding screen. Then, compound 5 was added to a final concentration of 1 mM, and the reaction was allowed to proceed for 11 h at room temperature. The protein was then removed by an Amicon Ultra 10K filter, and the reaction mixture was derivatized with Fmoc-Cl as previously described 8 . A negative control was also run with the same reaction mixture but without any FzmO. After derivatization, the reactions were analyzed by LC-MS using an Agilent 1200 series LC system coupled to an Agilent G1956B single quadrupole mass spectrometer with an Xbridge C18 column (4.6 x 250 mm, 5 µ) using mobile phase A (H2O) and mobile phase B (acetonitrile) at a flow rate of 1 mL/min. The method consisted of an isocratic hold at 5% B for 1 min, a linear gradient from 5% B to 95% B in 29 min, an isocratic hold at 95% B for 10 min, a linear gradient from 95% B to 5% B in 4 min, and a final isocratic hold at 5% B for 21 min. A positive control was also run wherein 500 µM Fmoc-derivatized glutamylhydrazine was spiked into the reaction mixture. Extracted ion chromatograms were generated using Agilent Chemstation software.
To test the activity of FzmA, 5 mM compound (6), 5 mM arginine, 6 mM MgCl2, 6 mM ATP, 6 mM thermostable inorganic phosphatase (New England Biosciences), and 21 µM FzmA were incubated in 50 mM NaH2PO4, pH=7.7 at ambient temperature for 21 h. A negative control was also run using the same conditions as above except that FzmA was withheld from the reaction mixture. After a passage a spin filter to remove enzyme, the reaction mixture was subjected to Fmoc-Cl derivatization as described above before analysis by LC-MS with an Agilent 1200 series LC system coupled to an Agilent G1956B single quadrupole mass spectrometer using a Grace Vydac C18 column To test the activity of KinL, E. coli BL21 (DE3) harboring pET28a-kinL was grown to OD600 ~ 0.5 before adding 0.2 mM IPTG, 1 mM of glutamic acid, and 1 mM of acetylhydrazide or hydrazine. A parallel control with BL21 (DE3) harboring an empty pET28a vector was also prepared. The cells were allowed to grow overnight at 15 ˚C.
The next day, the cultures were centrifuged, and 0.5 mL of the supernatant was added to an equivalent volume of acetone. The samples were centrifuged to remove precipitates and analyzed by LC-HRMS using an Agilent 1200 series LC system coupled to an Agilent qTOF 6530 mass spectrometer. The column used was a Cogent Diamond Hydride column (3 x 150 mm, 4 µ) using mobile phase A (H2O + 0.1% formic acid) and mobile phase B (acetonitrile + 0.1% formic acid) at a flow rate of 0.5 mL/min. The method consisted of an isocratic hold at 10% A for 1 min, a linear gradient from 70% A to 10% A in 19 min, an isocratic hold at 70% A for 1 min, a linear gradient from 70% to 10% A in 4 min, and an isocratic hold at 10% A for 4 min. For LC-HRMS analysis, the same assays were performed in final volumes of 50 μL. The assay mixtures were then analyzed by LC-HRMS in an analogous manner to the procedure for detecting isotopically labeled kinamycin D with the exception that the column used was an Acclaim TM Polar Advantage C18 column (ThermoFisher Scientific) (2.1 x 150 mm, 3 µ) and negative ion mode was used. To confirm the consumption of 3 in the activity assay of KinNM, the liquid chromatographic method for detecting 5 was used.
Chemical synthesis of substrates and standards
The procedures for the chemical synthesis of the various substrates and standards are described in the Supplementary Information. 
